SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-19-002533
Filing Date
2019-05-10
Accepted
2019-05-10 07:32:18
Documents
4
Period of Report
2019-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 16923
2 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION ipix_ex31.htm EX-3.1 132554
3 FORM OF SERIES 4 WARRANT ipix_ex41.htm EX-4.1 64608
4 FORM OF WARRANT RESTRUCTURING ipix_ex101.htm EX-10.1 35821
  Complete submission text file 0001477932-19-002533.txt   251324
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 19812848
SIC: 2834 Pharmaceutical Preparations